Truepill's COVID-19 test coverage platform will give clients a behind-the-scenes partner who can assist with everything from checking member eligibility for coverage to processing test orders and delivering tests to members' homes.
At a time when a large portion of healthcare practitioner interactions have switched to digital, it's clear that life science companies need to transform their approach to be much more collaborative in the way they work with healthcare professionals.
A new survey from Reuters Events in collaboration with Microsoft and Exeevo, Medical-commercial collaborating to win in the digital era, offers an inside look at the trends and challenges with which life science professionals have to contend, and how they are responding and explores new strategies and tactics for how these companies are working with healthcare providers and adapting themselves to improve the patient experience in healthcare.
By Microsoft and MedCity News Tuesday, January 25, 2022 7:30 AM
The report, Resilience in volatility: Modernizing the supply chain, highlights three areas that Fortune 500 and mid-size companies need to address to implement technology such as machine learning, cloud computing and risk management tools to improve production and delivery.
Physicians may soon have a solution that could be ideal for preventing surgical site infections with a combined multi-layered system that provides the surgical site with controlled and continuous delivery of antibiotics.
By Michelle Andrews, Kaiser Health News Monday, January 24, 2022 6:41 PM
It turns out that the laws governing traditional Medicare don't provide for coverage of self-administered diagnostic tests. Medicare patients are left to seek free tests other ways, including through the administration's new website, covidtests.gov, and at community centers.
BenchSci's technology uses artificial intelligence to make drug R&D faster and more efficient. Big pharmaceutical companies and clinical-stage biotechs are current users of the software, and BenchSci said it will use its new funding to expand the technology.
By Frank Vinluan Monday, January 24, 2022 12:21 PM
Merck is still at the front of the pack of companies developing new medicines to treat chronic cough, but the company was dealt a setback as the FDA turned down the pharma giant's application and asked for additional efficacy data. No safety issues were raised, according to Merck.
Every company will eventually face an audit. Download this FREE general audit checklist to evaluate your organization and take proactive steps guaranteed to prepare you in order pass an audit when the time comes.
No comments